Yahoo España Búsqueda web

Search results

  1. martin.kampmann@ucsf.edu. +1 415 514-5545. Research Overview: The Kampmann lab develops and applies innovative technologies to understand cellular and molecular mechanisms of human diseases, and to discover new therapeutic strategies. A major focus of our research are neurodegenerative and neuropsychiatric diseases.

  2. Biochemistry and Biophysics. martin.kampmann@ucsf.edu. +1 415 514-5545. The Kampmann lab develops and applies innovative technologies to understand cellular and molecular mechanisms of aging-associated neurodegenerative diseases, and to discover new therapeutic strategies. A major focus of our research are Alzheimer's disease and related dementias.

  3. 29 de feb. de 2012 · Martin Kampmann recaps his breakthrough performance from UFC Fight Night 6 against Crafton Wallace. This was the pilot episode of the Breakthrough series and...

  4. www.ufcespanol.com › athlete › martin-kampmannMartin Kampmann | UFC

    KO de la Semana: Johny Hendricks vs. Martin Kampmann Lo mejor de Condit y Kapmann 00:53. Nocaut de la semana: Hendricks vs. Kampmann Fight Night Belo: Dana Vlog UFC 154 Highlights UFC 154: Martin Kampmann's Open Workout UFC 154: Official Weigh-Ins UFC ...

  5. UFC 139 results: Martin Kampmann defeats Rick Story by split decision (29-28 Story, 30-27 Kampmann, 29-28 Kampmann) Martin Kampmann is a Dutch kickboxer turned mixed martial artist.

  6. Redaktør og tilrettelægger i Event & Udvikling under DR Nyheder. Det er her, vi løfter store begivenheder som valgdækning, mærkedage og tilbagevendende shows. Sideløbende er vi så priviligerede, at vi har tid til at udvikle nye formater på tværs af platforme. Vi udvikler både ind i eksisterende begivenheder og uden om begivenheder.

  7. A high-throughput CRISPR interference screen for dissecting functional regulators of GPCR/cAMP signaling. 2020-09-02 | Other. DOI: 10.1101/2020.09.02.279679. Contributors : Khairunnisa Mentari Semesta; Ruilin Tian; Martin Kampmann; Mark von Zastrow; Nikoleta G. Tsvetanova.